DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells

Cancer Research

Volumn 61, Issue 4, 2001, Pages 1659-1665

  Jahr, Sabine ^a   Hentze, Hannes ^a   Englisch, Sabine ^a   Hardt, Dieter ^a   Fackelmayer, Frank O ^a   Hesch, Rolf Dieter ^a   Knippers, Rolf ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; PARACETAMOL; STAUROSPORINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; CPG ISLAND; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; DNA FRAGMENTATION; DNA, NEOPLASM; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICE; MICE, INBRED BALB C; NECROSIS; NEOPLASMS; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 0035866393     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Radioimmunoassay for nanogram quantities of DNA
2. Free DNA in the serum of cancer patients and the effect of therapy
3. Plasma DNA level as a tumor marker in primary lung cancer
4. Plasma DNA as a marker of cancerous cell death. Investigation in patients suffering from lung cancer and in nude mice bearing human tumour
5. Neoplastic characteristics of the DNA found in the plasma of cancer patients
6. Soluble normal and mutated DNA sequences from single-copy genes in human blood
7. Microsatellite alterations in serum DNA of head and neck cancer patients
8. Microsatellite alterations in plasma DNA of small cell lung cancer patients
9. Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma
10. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients
11. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients
12. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum from non-small cell lung cancer patients
13. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients
14. Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis
15. A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates
16. Improved polymerase chain reaction detection of clonally rearranged T-cell receptor β chain genes
17. Methylation-specific PCR, a novel PCR assay for methylation status of CpG islands
18. Intracellular adenosine triphosphate concentration: A switch in the decision between apoptosis and necrosis
19. The novel SAR-binding domain of scaffold attachment factor A (SAF-A) is a target in apoptotic nuclear breakdown
20. Apoptotic cleavage of scaffold attachment factor A (SAF-A) by caspase-3 occurs at a noncanonical cleavage site
21. Depletion of hepatic glutathione prevents death receptor-dependent apoptotic and necrotic liver injury in mice
22. Lethal effect of the anti-Fas antibody in mice
23. T-cell responses at the host: Tumour interface
24. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
25. 5′CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
26. Alterations in DNA methylation: A fundamental aspect of neoplasia
27. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation
28. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
29. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B
30. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
31. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma
32. DNA-methylation of the E-selectin promoter represses NF-κB transactivation
33. Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins
34. Apoptotic DNA fragmentation
35. Phagocytic docking without shocking
36. Cytokine-mediated hepatic apoptosis
37. Tumor angiogenesis
38. K-ras gene mutations in the plasma of colorectal cancer patients
39. Apoptosis in serum of patients with solid tumors
40. Life (and death) in a malignant tumour
41. Apoptosis: The importance of being eaten